Down syndrome (DS) is the most common cause of mental retardation. Many neural phenotypes are shared between DS individuals and DS mouse models; however, the common underlying molecular pathogenetic mechanisms remain unclear. Using a transchromosomic model of DS, we show that a 30%-60% reduced expression of Nrsf/Rest (a key regulator of pluripotency and neuronal differentiation) is an alteration that persists in trisomy 21 from undifferentiated embryonic stem (ES) cells to adult brain and is reproducible across several DS models. Using partially trisomic ES cells, we map this effect to a three-gene segment of HSA21, containing DYRK1A. We independently identify the same locus as the most significant eQTL controlling REST expression in the human genome. We show that specifically silencing the third copy of DYRK1A rescues Rest levels, and we demonstrate altered Rest expression in response to inhibition of DYRK1A expression or kinase activity, and in a transgenic Dyrk1A mouse. We reveal that undifferentiated trisomy 21 ES cells show DYRK1A-dosesensitive reductions in levels of some pluripotency regulators, causing premature expression of transcription factors driving early endodermal and mesodermal differentiation, partially overlapping recently reported downstream effects of Rest þ/À. They produce embryoid bodies with elevated levels of the primitive endoderm progenitor marker Gata4 and a strongly reduced neuroectodermal progenitor compartment. Our results suggest that DYRK1A-mediated deregulation of REST is a very early pathological consequence of trisomy 21 with potential to disturb the development of all embryonic lineages, warranting closer research into its contribution to DS pathology and new rationales for therapeutic approaches.
Introduction
Down syndrome (DS [MIM 190685] ) is a complex condition characterized by many phenotypic features, including mental retardation, smaller brain size, reduced numbers of neurons, reduced dendritic spine density and plasticity, and early-Alzheimer's-disease-like neurodegeneration. 1, 2 Mouse models for DS also display behavioral and cognitive defects, synaptic plasticity defects and long-term potentiation (LTP) deficit in the hippocampus, and reduced hippocampal and cerebellar neuron numbers. [3] [4] [5] [6] [7] [8] However, despite these similarities, causative mechanisms common to human and mouse DS systems remain to be elucidated. Cultured fetal DS brain cell-derived neurospheres were found to have decreased transcript levels of neuron-restrictive silencer factor (NRSF or REST [MIM 600571]) and downstream targets such as SCG10 9 [MIM 600621]. REST modulates expression of genes encoding fundamental neuronal functions including ion channels, synaptic proteins, and neurotransmitter receptors. [10] [11] [12] [13] [14] [15] It is essential both for the repression of these genes in non-neuronal tissues 10 and for the orchestrated activation of transcription of these genes during neuronal differentiation, acting as a silencer or as a transcription activator. [12] [13] [14] [16] [17] [18] Coordinated activation of transcription of REST targets is both necessary and sufficient for the transition from pluripotent embryonic stem (ES) cells to neural progenitor cells (NPCs) 14 and onward to mature neurons, 13, 14 and the REST pathway has been implicated in an inherited form of mental retardation. 19 Using a transchromosomic mouse model of DS, we show here that a reduced expression of Rest is an alteration that persists from undifferentiated ES cells to the adult brain and is reproducible across several DS models. We map the region capable of affecting Rest levels in both mouse and human cells to the DYRK1A 20 We demonstrate that trisomy 21 ES cells share certain aspects of the aberrant control of pluripotency and early differentiation reported in Rest þ/À cells, 20 suggesting that DYRK1A-mediated deregulation of REST could be an important potential contributor to a variety of DS phenotypes.
Material and Methods

Material
All general reagents and tissue-culture media were from Sigma (Dorset, UK) unless otherwise stated, and all primers were supplied by Invitrogen (Paisley, UK). Transchromosomic ES cells 47-1, 40-2, and 46-1 were derived from D3 ES cells by the introduction of all or parts of HSA21 via microcell-mediated chromosome transfer. 21 Mapping data for 40-2 and 46-1 have been previously published, 21 and they were verified and refined to the single-gene resolution in the current study (data available upon request). Antibodies were as follows: anti-REST from Upstate, anti-GAPDH from Invitrogen (ZYMED laboratories), and anti-PTEN from Abcam. Anti-b-actin, anti-calnexin, and anti-b tubulin isotype III antibodies were from Sigma. Sequences of primers and probes used for quantitative RT-PCR and linkage analysis are available in Table S3 , available online. EGCG (epigallocatechin gallate) was from Sigma. The Dual-Luciferase Reporter Assay System was from Promega.
Mice
Tc1 mice backcrossed to C57BL/6J (2-3 generations) and Ts1Cje mice backcrossed to C57BL/6J (> 10 generations) were maintained at the National Institute for Medical Research in accordance with UK Home Office regulations. 8 The TgDyrk1A mice were maintained on C57BL6/SJL background in the facility of the Genes and Disease Program, Center for Genomic Regulation. Whole brain hemispheres from 6-to 11-month-old adult mice were used. In all comparisons, sex-matched littermates were used.
ES Cell Culture and Differentiation
Pluripotent D3 and 47-1 ES cells were seeded onto embryonic-fibroblast feeder layers and were maintained in DMEM with 15% fetal-calf serum (Hyclone), 2 mM glutamine, 1 3 nonessential amino acids (Invitrogen), 50 U/ml penicillin, 50 mg/ml streptomycin, 1:150,000 b-mercaptoethanol, and 10 3 U/ml LIF-ESGRO (Chemicon). For the first passage, transchromosomic cells were cultured in ES medium with 500 mg/ml G418 for ensuring retention of HSA21. Cells were cultured without G418 for a second passage, for minimization of differences in culture conditions between wild-type (WT) and transchromosomic cells, and without G418 or feeders for the final passage before extraction, for minimization of background from feeder cells. Transchromosomic cells were verified by FISH as retaining HSA21 in > 90% of cells, with the use of human Cot1 probe as described previously. 21 For differentiation into NPCs, D3 and 47-1 cells were treated as described. 22 In brief, cells were cultured in the absence of LIF to form embryoid bodies, which were then treated with 5 mM RA for four days before dissociation 22 and replating onto poly-D-lysine-and laminincoated dishes in Neurobasal N2 medium (Invitrogen).
Immunofluorescence was carried out as described. 14 Table S5 , and unpublished data]; red bar indicates equivalent mouse chromosome 16 segment 5 ) in trisomy 21 models. The box delineates the minimal trisomic region correlating with Rest suppression.
Luciferase Assay
Mouse Rest transcript NM_011263 promoter sequence (1013 bp) was inserted into the PGL-3 basic vector, upstream of the firefly Luciferase reporter gene. Rest-PGL-3 was cotransected with the pRL-CMV expression vector into D3 cells with Lipofectamine 2000 (Invitrogen), according to the manufacturer's specific protocol for D3 cells with minor modifications. Luciferase activity was measured with the Dual-Luciferase Reporter assay system (Promega). Renilla luciferase activity was used for standardization of transfection efficiency.
Protein Analysis
For Western blotting, D3 and 47-1 ES cells were solubilized in 30 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM NaF, 1 mg/ml leupeptin, and 5 KU/ml aprotinin containing 1% Triton X-100. The lysate was clarified by centrifugation at 435,000 3 g max for 30 min at 4 C. Immunoblot analyses were performed as described previously. 23 Western blotting of brain homogenates was performed as described previously.
24
Human-Genome Linkage Analysis 
Results
Decrease in Rest Level Is an Early and Persistent Phenotype of Trisomy 21
We sought to examine transcripts altered by trisomy 21 in pluripotent, undifferentiated mouse ES cells. For this purpose, we compared the transchromosomic mouse ES cell line 47-1, which was engineered to contain a whole HSA21 on an otherwise euploid mouse genome, 21 with parental D3 cells using Affymetrix MG-U74Av2 mouse arrays (n ¼ 4). Unsupervised hierarchical clustering successfully segregated 47-1 from D3, indicating a global perturbation of transcription by trisomy 21 ( Figure 1A ). Rest was found among the eight most significantly decreased mouse transcripts ( Figure S1 and Tables S1 and S2). Given that Rest had previously been found reduced only in DS fetal brain cells, 9 its apparent reduction in pluripotent ES cells would provide a new insight; we decided to investigate this further. Rest suppression in 47-1 cells was verified by quantitative RT-PCR ( Figure 1B ). Both alternatively spliced forms of the transcript (Rest 1 and Rest 4) were significantly decreased ( Figure 1C ; see Table S3 for all primer sequences), suggesting that suppression occurs at the level of transcription rather than alternative splicing. Suppression of Rest protein was verified by Western blotting of whole cell lysates, in which a single 200 kD band was seen ( Figure 1 ). Rest protein level was highly significantly reduced, by > 40%, irrespective of the protein used for normalization (Gapdh, Calnexin, Pten, or all three; Figure 1D ). In order to prove that Rest suppression is not simply a clone-or system-specific artifact, we measured Rest transcript levels in an independently derived transchromosomic ES cell line carrying a smaller portion of HSA21 (40-2) 21 and in adult brains from two independent mouse models of DS: (1) transchromosomic Tc1 mice, which model a range of features of DS, including changes in behavior, synaptic plasticity, cerebellar neuronal number, congenital heart defects, and skeletal malformations; 8 and (2) Ts1Cje mice, which are trisomic for a segment of mouse chromosome 16 carrying mouse orthologs of 85 HSA21 genes 5 and display DS neurological phenotypes similar to those of Tc1 mice. [5] [6] [7] All three systems showed a 34%-41% reduction of
Rest transcript levels compared to WT ( Figures 1E-1G ).
Other tissues of the DS mouse models also showed a decrease in Rest and altered dose of some of the genes containing NSRE elements 27 that Rest binds to (examples shown in Figure S2 ).Therefore, Rest suppression persists from ES cells to the adult brain, it is reproducible regardless of differences in genetic background and the species of origin of the extra chromosome, and, importantly, it is a phenotype shared between several DS mouse models ( Figure 1F , Figure S2 ) and human DS. 
Rest-Level Control Maps to DYRK1A Locus in Mouse ES Cells and Human Lymphoblastoid Lines
Combining results from the different model systems yielded a minimal trisomic region sufficient to cause Rest suppression, mapped to a~2 Mb HSA21 interval. In order to dissect this region further, we used another ES cell line , from the same panel as 40-2, which is not trisomic for three genes in the candidate region. Because this cell line showed no significant reduction in Rest levels ( Figure 1E ), the minimal candidate region for Rest reduction could be mapped to only three genes: TTC3, DSCR3, and DYRK1A ( Figure 1F ). As an alternative, independent approach to identifying loci that regulate REST-gene expression, we undertook a human genome-wide eQTL analysis. 25, 28, 29 We measured variation of REST transcript levels in human lymphoblastoid cell lines of 135 individuals from ten three-generation CEPH families. Interindividual differences in REST expression were observed (variance ratio ¼ 4.7), with a significant proportion of this variability having a genetic component Figure 2A ) mapped to a 3 Mb genomic region on HSA21 that overlaps with the minimal region responsible for Rest suppression in mouse models of DS ( Figure 2B ; highlighted square). Figure S3 . Data are shown normalized to control samples transfected with a nontargeting ''scrambled'' RNAi sequence. Means and standard errors are shown, and statistical significance by Student's t test is indicated by one (p < 0.05) or two (p < 0.01) asterisks.
DYRK1A Dosage Imbalance Perturbs Rest Levels
These data, taken together, allowed us to hypothesize that one or more of the three genes in the minimal candidate region (TTC3, DSCR3, or DYRK1A) would control Rest transcript levels in mice and humans. In order to test this hypothesis, we used RNAi oligonucleotides to specifically silence the three genes, individually or in pairs, in normal, pluripotent, undifferentiated mouse E14 ES cells (for sequences of all siRNA reagents, see Table S4 ; silencing effectiveness was measured by quantitative RT-PCR; see Figure S3 ). Rest mRNA levels specifically responded only to the dose of Dyrk1A and not to the other two genes ( Figure 2C) . Interestingly, the level of Rest was reduced when the Dyrk1a transcript was suppressed ( Figure 2C ). We then used human-specific DYRK1A RNAi oligonucleotides (targeting the 3 0 UTR) to silence only the products of the third copy of the DYRK1A gene in transchromosomic 47-1 ES cells. This approach only partially succeeded in suppressing human DYRK1A mRNA (~0.5-fold; Figure 3A) , with no significant effect on mouse Dyrk1A (not shown). This correction was sufficient for rescuing Rest levels to within the range of normal (D3 control) values ( Figure 3A) . This provides strong evidence that Rest dysregulation is mediated by DYRK1A. The effect of the selective DYRK1A-kinase inhibitor, epigallocatechin gallate (EGCG), 31 on Rest expression was then assessed. Short-term culture with the inhibitor slightly reduced Rest levels in D3 cells but had little effect on trisomic 47-1 cells ( Figure 3B ). Longer treatment significantly reduced Rest levels in both cell lines as compared with untreated cells (Figure 3B ), in concordance with the effect of complete RNAi silencing of DYRK1A ( Figure 2C , Figure S3 ). We also observed an inhibitory effect of EGCG on the Rest-promoter activity in undifferentiated ES cells ( Figure 3C ). Lastly, we studied Rest in brains from adult Dyrk1A transgenic (TgDyrk1A) mice, which display several DS-related neural phenotypes and show a 1.94-fold increase in Dyrk1A protein levels. 24 A significant (~30%) reduction of Rest mRNA was observed ( Figure 3D ), demonstrating that the increased Dyrk1A gene dosage is sufficient to cause the suppression of Rest, to an extent similar to that observed in brains of DS mouse models. These data suggest that Rest expression is very sensitive to the level of Dyrk1A, with both over-and underexpression of Dyrk1A resulting in Rest suppression. The DYRK1A-inhibitor data implicate DYRK1A phosphorylation in the mechanism behind this effect. Our data cannot exclude the possibility that other HSA21 genes cooperate with DYRK1A in modulating the Rest levels. The potential contribution of several other genes from the eQTL region was considered: DOPEY2, which was implicated in cerebellar morphogenesis, 32 is not expressed at the blastocyst stage (Unigene database), whereas Cbr1, recently highlighted as a strong potential candidate for the generation of DS phenotypes, 33 and Setd4 were both ruled out by the demonstration that their respective RNAi knockdowns had no effect on Rest levels in mouse ES cells (see Figure S4 ). Much more detailed analysis would have to be carried out for the examination of additional contributory effects of all other HSA21 genes.
DYRK1A-Rest Deregulation Disturbs Pluripotency and Embryonic Stem Cell Fate
Our data show that the level of Rest is approximately halved in undifferentiated trisomy 21 ES cells (Figure 1 ). It was recently reported that Rest þ/À cells show reduced levels of key regulators of pluripotency, Oct4, Nanog, and Sox2, resulting in aberrantly premature expression of differentiation-driving transcription factors (TFs). 20 The differences in the levels of Oct4, Nanog, and Sox2 in our microarray data were not above the rigorous significance cutoff thresholds. However, when their expression was more sensitively tested by qRT-PCR on a larger number of independent cultures (n ¼ 9), a result partially overlapping with that of Rest þ/À cells 20 was obtained: Oct4 levels were not significantly changed, but Nanog and Sox2 were both significantly reduced in trisomy 21 ES cells ( Figure 4A ). Next, we measured the levels of several TF drivers of embryonic-layerspecific differentiation (downstream targets of Oct4, Nanog, and Sox2) that were increased in Rest þ/À cells. 20 Figure 4B , Tables S1 and S2 ). We then demonstrated that the reduced levels of Nanog and Sox2 in 47-1 cells could be partially restored (though still not reaching the levels in D3 cells; not shown) by human-specific DYRK1A RNAi transfection ( Figure 4C ), similar to Rest ( Figure 3A) . The partial knockdown of human DYRK1A in this experiment did not significantly alter the levels of lineage-specific TFs (not shown), probably because it would take a stronger and more lasting knockdown to stimulate the cascade of events in the reassembly of the complexes repressing the transcription of these TFs once they had been derepressed. We then investigated whether the drastic reduction in Rest caused by a 24 hr incubation with DYRK1A-kinase inhibitor in normal mouse D3 cells had any effects on the pluripotency-regulating network. This treatment reduced the level of Rest in D3 cells by 3.5-fold ( Figure 3B ), and it was also sufficient to trigger a reduction in the levels of Nanog and Sox2 and a premature increase in the expression of endodermal and mesodermal TFs Foxa2, Gata4, and Snai1 ( Figure 4D ). Taken together, these data show that the pluripotency-regulating network is disturbed in trisomy 21 ES cells in a specific way, which is similar in part to the disturbance reported for the heterozygous knockout of Rest, 20 and that this deregulation is partially sensitive to the dose and enzymatic activity of DYRK1A. When we allowed the ES cells to differentiate into embryoid bodies (EBs), the trisomy 21 EBs (47-1) and 5B 0 ). There was also a trend toward an increase in abnormal branching in 47-1-derived neurons, compared with D3 neurons ( Figure 5C ), quantified as an altered ratio of secondary to primary neurites (see Figure S5 ). These data reproduce the main features of the neurogenesis defect previously reported for human DS fetal neurospheres. 9 
Discussion
Dual-specificity tyrosine-phosphorylated and -regulated kinase, DYRK1A, is a well-characterized HSA21 gene and ortholog of the Drosophila minibrain (mnb) gene, whose mutation causes abnormal spacing of neuroblasts and reduced production of neuronal progeny in Drosophila. Figure S5 for quantitative analysis of neurite branching. In all graphs, means and standard errors are shown, and statistical significance by Student's t test is indicated by one (p < 0.05), two (p < 0.01), or three asterisks (p < 0.001).
Dosage imbalance of DYRK1A together with DSCR1 (MIM 602917) (also on HSA21) has been reported to cause a dysregulation of the NFATc (MIM 602699) pathway in DS. 35 This mechanism is most likely independent of the Rest dysregulation we report here, given that DSCR1 is not trisomic in two systems showing Rest reduction in our experiments and that the Rest reduction we observe developmentally precedes the changes in NFATc. We report a downregulation of Rest mRNA in adult brains of three different DS mouse models-Tc1, Ts1Cje, and TgDyrk1A-compared to their WT littermates (Figures 1G and 3D) . Interestingly, all three of these mouse models and a fourth mouse model that is trisomic for four HSA21 genes, including DYRK1A (Tg152f7), share learning and memory deficits, motor defects, including hyperactivity and other behavioral changes, and LTP deficits in the hippocampus or other signs of hippocampal dysfunction. [4] [5] [6] [7] [8] 24 This comparison between the yeast artificial chromosome (YAC)-transgenic, gene-transgenic, and segmental-trisomy models should be taken with a degree of caution, because even though there is a hippocampal dysfunction in both models, the reasons behind each could be different. Also, the impact of Dyrk1A overexpression could be different in different genetic backgrounds within disomic or trisomic contexts and in different brain regions. Our data are partly in contradiction with a recently generated 33-gene trisomy model of DS, Ts1Rhr, that shows no hippocampal-volume change and no electrophysiological and behavioral defects associated with hippocampal functions despite having three copies of Dyrk1A. 36 However, given that (1) crossing the Ms1RhR reciprocal-deletion model to the Ts65DN mouse model rescues most of the latter model's cognitive phenotypes 36 and that (2) TgDyrk1A mouse models show compelling phenotypes, 4, 24 it is likely that additional factors, such as strain-specific modifier genes, might account for the apparent contradiction. Additional studies on the Ts1RhR mouse model are clearly necessary to explain these discrepancies. Interestingly, monosomy of this 33-gene segment (mouse model Ms1RhR) produced striking reductions in hippocampal volume, 36 comparable to the severe reduction in brain size and morphology in Dyrk1Aþ/À mice 37 and consistent with the fact that truncation of DYRK1A in humans causes microcephaly. 38 This result is compatible with our observation that downregulation of Dyrk1A below physiological (disomic) levels drastically reduces Rest level ( Figure 2C , Figure 3B ), thereby deregulating early differentiation and decreasing the relative proportion of neuroectodermal progenitors. In support of this explanation, an early developmental function for Rest has also been demonstrated in other models: Rest-knockout mice exhibit early embryonic lethality, 39 and RNAi strategies in Xenopus revealed that a reduced transcriptional dose of Rest causes incorrect patterning of the ectoderm and abnormal neurogenesis. 40 The observation that both overdose and inhibition of Dyrk1A have the same consequence of reducing the Rest transcript level is intriguing. Several different hypotheses could explain this phenomenon. It is plausible that an imbalance could occur in a multiprotein complex regulating REST transcription, subcomponents of which could be DYRK1A targets. Such mechanisms have been previously demonstrated in yeast, in which under-or overexpression of single subunits of a multiprotein complex reduced the fitness of the complex as a whole with an equal outcome. 41 We also identify the DYRK1A locus on 21q22 as the most significant eQTL for the control of Rest level in human lymphoblastoid lines (LBLs) (Figures 2A and 2B) . Interestingly, this locus, as well as the next two most likely eQTLs (9q22 and 6q27; Figure 2A ), form three of the 12 loci genomewide, with the suggestive linkage to Alzheimer's disease (AD, [MIM 104300]), in a study of 437 families. 42 It might be interesting to examine the roles of DYRK1A and REST in aging and survival of neurons, as well as in pathogenesis of AD. DYRK1A displays a dynamic spatio-temporal pattern of expression during mouse brain development. 43 Its expression in preneurogenic and neurogenic progenitors 43 places it at the critical point when a sudden change in the level of Rest transcription takes place, 14 after the proteolytic degradation of Rest triggers the exit from ES to preneurogenic progenitor. The transient burst of DYRK1A expression in the asymmetric neuronal-progenitor cell division fits with its potential role as the trigger for neuro-differentiation commitment. 43, 44 Our data suggest that one of the mechanisms by which DYRK1A could exert this triggering role could be through precipitating local spatio-temporal changes in the level of Rest. Repertoire of downstream target genes regulated by REST is critically dependent on the level of REST, 14, 27, 45 regulation and maintenance of which is not fully understood. Differentiation is triggered by an orchestrated reduction in Rest levels, which is mediated both by ubiquitin-dependent proteolytic degradation and by control of transcription. 14, 46 Forced partial knockout of Rest destabilizes a complex network of miRNAs and proteins responsible for the maintenance of self-renewal and pluripotency of both human and mouse ES cells. 20, 47, 48 This produced a premature and aberrant expression of differentiation-driving TFs of all embryonic lineages in undifferentiated ES cells. 20 Our data (Tables S1 and S2 , Figures 4A and 4B) show that the halving of Rest dose by trisomy 21 reproduces many of these perturbations (decreased levels of Nanog and Sox2 and increased levels of Gata4, Gata6, Foxa2, Snai1, and Pitx2), but not all of them (Oct4 and Fgf5 levels are unchanged). The reasons for these differences are unclear and require additional investigation, but they are likely to result from the trisomic contribution of other HSA21 elements. Nevertheless, the reduction in Rest has the potential to significantly perturb the pluripotency network in trisomy 21 ES cells, and this perturbance seems to be partially sensitive to the dose and kinase activity of DYRK1A ( Figures 4C and  4D ). DYRK1A is localized in the cell nuclei and/or cytoplasm, depending on the specific cell type, and some of its phosphorylation targets include histone subunits and TFs. [49] [50] [51] The potential contribution of other HSA21 genes to this deregulation remains to be investigated. We cannot rule out the possibility that DYRK1A-kinase activity affects other regions in the Rest promoter, besides affecting transcription from the promoter region, shown in Figure 3C (though we ruled out any significant contribution from several other regions, totaling 1393 bp of the Rest promoter; data available on request). We also cannot rule out the possibility that DYRK1A-kinase activity affects other unknown targets within the complex miRNA-protein-regulatory network, whose back-and forward-feeding loops control levels of Rest, Oct4, Nanog, and Sox2. 20, 47, 48 ES cells with premature expression of differentiationdriving TFs have been reported to give rise to EBs with increased lineage-specific progenitors. 20 To test if this phenomenon could be reproduced in trisomy 21 ES cells, we differentiated the 47-1 and D3 cells for 8 days in the absence of LIF, as well as in the presence of retinoic acid. Consistent with the premature expression of TFs observed in the trisomy 21 ES cells, their differentiation into EBs resulted in a skewed ratio of lineage progenitor markers: compared with normal (D3) cells, the trisomic (47-1) cells produced EBs with higher levels of Gata4 (a marker of extra-embryonic endoderm and heart development) and reduced markers of the EB neuroectodermal compartment (nestin, Tubb3, and Map-2) ( Figure 5A ). Neurogenesis starting from such EBs was retarded (
Figure 5B shown that human fetal-brain neurospheres display a severely reduced ability to form neurons, compared to neurospheres grown from age-matched euploid feti. 9 The DS neurospheres also produced neurons with abnormally branched neurites, 9 a result reproduced by our transchromosomic ES cells ( Figure 5C and Figure S5 ) and by partial REST siRNA knockdown in a differentiating NPC cell line. 53 Taken together, these data suggest that the DYRK1A-REST perturbation has the potential to significantly contribute to the development of defects in neuronal number and morphology in DS. The premature reduction in REST levels could skew cell-fate decisions to give rise to a relative depletion in the number of neuronal progenitors, and the same reduction in REST levels could cause an aberrantly accelerated differentiation of each progenitor, producing abnormally highly branched neurons.
In summary, we have demonstrated that Rest levels are disturbed at a very early developmental stage in trisomy 21 ES cells (preceding ES cell differentiation) and shown this disturbance to be dose-sensitive to the level and activity of DYRK1A. Our results suggest that this deregulation has the potential to disturb the development of all embryonic lineages, warranting more detailed research into its contribution to all aspects of DS pathology and rationales for novel therapeutic approaches.
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